Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Regenerative Medical Technology Group
AddedFeb 20, 2024
UpdatedJul 4, 2026
Regenerative Medical Technology Group

Regenerative Medical Technology Group

Meso Numismatics: A global innovator in coin collection and technology, operating as a museum and art gallery.

HQ
Boca Raton, FL, US
Founded
2001
Overview
Compare
Employees
Website

Meso Numismatics, Inc. was founded with a core mission to innovate in the field of coin collection and numismatic technology. Operating as both a museum and art gallery, the company specializes in collecting and preserving ancient coins and currency. Meso Numismatics serves a global market, offering a wide range of rare and valuable numismatic items, including coins from El Salvador, Costa Rica, and Nicaragua. Their vision is to bridge the gap between historical preservation and modern technology, making numismatics accessible to enthusiasts worldwide.

Notable figures associated with Meso Numismatics include experts in numismatics and technology who have contributed to the company's innovative approach. The company has achieved significant milestones, such as curating an extensive collection of rare coins and gaining recognition in the numismatic community. By leveraging technology, Meso Numismatics has enhanced the way collectors interact with and acquire numismatic items, thereby having a substantial impact on the industry.

Similar Companies

Mini Museum logo

Mini Museum

minimuseum.com

GoCollect logo

GoCollect

gocollect.com

Collectibles.com logo

Collectibles.com

Asset Marketing Services logo

Asset Marketing Services

amsi-corp.com

Osiris Exchange logo

Osiris Exchange

Coin & Card Auctions logo

Coin & Card Auctions

Goldin Auctions logo

Goldin Auctions

MuseumShop logo

MuseumShop

1stDibs logo

1stDibs

Magpie logo

Magpie

Americana Technologies logo

Americana Technologies

americana.io

Arkive logo

Arkive

arkive.net

Gmoney NFT logo

Gmoney NFT

y.at

MuseumNetwork.com logo

MuseumNetwork.com

museumnetwork.com

Curio logo

Curio

curio.tools

Regenerative Medical Technology Group - Quick Facts

Who are Regenerative Medical Technology Group's competitors?

Companies similar to Regenerative Medical Technology Group include Mini Museum, GoCollect, Collectibles.com and Asset Marketing Services.

When was Regenerative Medical Technology Group founded?

Regenerative Medical Technology Group was founded in 2001.

Where is Regenerative Medical Technology Group's headquarters located?

Regenerative Medical Technology Group's headquarters is located in Boca Raton, FL, US.

How many employees does Regenerative Medical Technology Group have?

Regenerative Medical Technology Group has 5 employees as of Feb 5, 2024.

Regenerative Medical Technology Group - Classification

Industry
  • Retail
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Coin Collection
Tags
  • Art Gallery
  • Museum
Unique IDs
  • secCik: 0001760026
  • ticker: RMTG
NAICS
  • 712000Museums, Historical Sites, and Similar Institutions
  • 710000Arts, Entertainment, and Recreation
  • 712100Museums, Historical Sites, and Similar Institutions
  • 712110Museums
SIC
  • 5900Miscellaneous Retail
  • 5990Retail Stores, Not Elsewhere Classified
Show 7 more industry codes
SIC
  • 8390Social Services, Not Elsewhere Classified
  • 5000Wholesale Trade-durable Goods
  • 8300Social Services
  • 8400Museums, Art Galleries, And Botanical And Zoological Gardens
  • 8410Museums And Art Galleries
  • 8399Social Services, Not Elsewhere Classified
  • 8412Museums and Art Galleries